P-881

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameP-881
Drug Alias NameR-spondin 3 antagonists (DKFZ)P-881
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionR-spondin-3 inhibitors
TargetsR-spondin-3
Therapy Area/IndicationsBone DiseasesBone Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGerman Cancer Research Center (Dkfz)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGerman Cancer Research Center (Dkfz)
Active IndicationsN/A
Inactive IndicationsBone DiseasesBone Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A